In agreement, we also found CD109 overexpression in the triple negative EGFR overexpressing breast cancer cell line MDA-MB-468, but not in the ER-, PR-, HER2 overexpressing cell line SKBR-3 (Figure 1; Supplementary Figure 2). This evidence concerns the gene EGFR and breast carcinoma.